CYH achieved a dramatic turnaround with net income swinging from -$516M loss to +$509M profit, while simultaneously reducing market footprint and workforce.
This represents a remarkable financial transformation, with the company moving from significant losses to substantial profitability while generating strong operating cash flows. However, the operational contraction—closing markets, reducing hospital networks, and cutting physician staff—suggests this turnaround may have come through aggressive cost-cutting and asset optimization rather than organic growth.
CYH delivered exceptional financial performance with net income improving by nearly $1 billion from a $516M loss to a $509M profit, while operating income more than doubled to $1.5B and operating cash flow grew 13% to $543M. The company dramatically strengthened its balance sheet with cash increasing over 600% to $260M and stockholders' equity improving by $500M, though still remaining negative at -$1.4B. The massive increase in share buybacks from $9M to $159M demonstrates management's confidence in the turnaround and commitment to returning cash to shareholders.
Share repurchases increased 1666.7% — management returning capital, signals confidence in intrinsic value.
Cash position surged 602.7% — strong cash generation or capital raise providing significant financial cushion.
Net income grew 198.6% — bottom-line growth signals improving overall business health.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Equity base grew 27.2% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Operating cash flow grew 13.1% — strong conversion of earnings to cash, healthy business fundamentals.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →